Alqahtani, T.;                     Kumarasamy, V.;                     Alghamdi, S.S.;                     Suliman, R.S.;                     Bin Saleh, K.;                     Alrashed, M.A.;                     Aldhaeefi, M.;                     Sun, D.    
        Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes. Cancers 2023, 15, 2163.
    https://doi.org/10.3390/cancers15072163
    AMA Style
    
                                Alqahtani T,                                 Kumarasamy V,                                 Alghamdi SS,                                 Suliman RS,                                 Bin Saleh K,                                 Alrashed MA,                                 Aldhaeefi M,                                 Sun D.        
                Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes. Cancers. 2023; 15(7):2163.
        https://doi.org/10.3390/cancers15072163
    
    Chicago/Turabian Style
    
                                Alqahtani, Tariq,                                 Vishnu Kumarasamy,                                 Sahar Saleh Alghamdi,                                 Rasha Saad Suliman,                                 Khalid Bin Saleh,                                 Mohammed A. Alrashed,                                 Mohammed Aldhaeefi,                                 and Daekyu Sun.        
                2023. "Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes" Cancers 15, no. 7: 2163.
        https://doi.org/10.3390/cancers15072163
    
    APA Style
    
                                Alqahtani, T.,                                 Kumarasamy, V.,                                 Alghamdi, S. S.,                                 Suliman, R. S.,                                 Bin Saleh, K.,                                 Alrashed, M. A.,                                 Aldhaeefi, M.,                                 & Sun, D.        
        
        (2023). Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes. Cancers, 15(7), 2163.
        https://doi.org/10.3390/cancers15072163